Scientists have progressed from merely provoking an anti-cancer immune response to designing it ...
Engineered immune cells called CAR-T cells are used in the treatment of cancer. Researchers from Uppsala University have now ...
Researchers found that bioengineered CAR-T cells when mixed with other immune cells can "donate" proteins, suggesting ...
Priya Hays, Hays Documentation Specialists, discusses innovations and advancements in the development of personalized cancer ...
Researchers at the University of Pennsylvania have introduced lab-engineered small extracellular vesicles to target tumors in ...
Professor Meghan Morrissey earns an innovation award to program immune cells to attack cancer tumors. #immunotherapy ...
Researchers at Cellectis leveraged gene editing to create a CAR T cell that acts in an IF/THEN system. Traditional methods to develop CAR T cells that use the patient’s cells introduce challenges ...
A phase 3 clinical trial has shown that adding a targeted immunotherapy drug to chemotherapy dramatically improved – almost ...
An approach using engineered small extracellular vesicles from NK cells to DR5 could be a promising strategy for solid tumors ...